| Friday 25 May 2007, London, UK |
| Led by: |
François Simon
Regional Liaison Manager,
Emerging Countries/EDC Specialist
MERCK SERONO |
SUCCESSFULLY MANAGING EDC AND E-CLINICAL TRIALS IN EMERGING MARKETS |
| |
|
|
| Workshop Agenda |
| 09.30 |
Registration |
|
| 10.00 |
Start of Workshop
|
Sessions will explore the following key issues:
- Where is the most diffi cult place to implement an EDC trial? Europe or "exotic countries"?
- What do we have to face in terms of authorisation from hospitals, internet connection facilities, motivation to use EDC and laptop deployment?
- Can cultural differences infl uence implementation of EDC?
- Practical task: mapping out the regional specifi cities for EDC implementation
|
| 12.30 |
Close of Workshop |
|
| |
|
|
| About the workshop leader |
| |
Merck Serono |
Merck Serono is a unique biotech company with a global presence and fully integrated from discovery to market. It is a world leader in the field of biotechnology. It competes for leadership in all markets in which it operates. Merck Serono’s competitive advantage is derived from achieving superior performance above and beyond the sum of its parts. In achieving its goals it
maximises its return on investment for its shareholders. Its overall aim is to develop innovative products to address unmet medical needs and improve quality of life of its patients. |
